IP Verse

Hyaluronic Acid Injectable Gel For Treating Joint Degeneration - EP2173324

The patent EP2173324 was granted to Anteis on Apr 10, 2019. The application was originally filed on Jul 2, 2008 under application number EP08827889A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2173324

ANTEIS
Application Number
EP08827889A
Filing Date
Jul 2, 2008
Status
Granted And Under Opposition
Mar 8, 2019
Publication Date
Apr 10, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LABORATOIRES VIVACYJan 10, 2020TRIPOZADMISSIBLE

Patent Citations (24) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONEP1732620
EXAMINATIONUS5106615
INTERNATIONAL-SEARCH-REPORTEP0297860
INTERNATIONAL-SEARCH-REPORTEP0499164
INTERNATIONAL-SEARCH-REPORTFR2865737
INTERNATIONAL-SEARCH-REPORTUS2003203030
INTERNATIONAL-SEARCH-REPORTUS5095037
INTERNATIONAL-SEARCH-REPORTUS5972909
INTERNATIONAL-SEARCH-REPORTWO2006067608
OPPOSITIONEP1732620
OPPOSITIONUS2003203030
OPPOSITIONUS5079236
OPPOSITIONUS5095037
OPPOSITIONUS5106615
OPPOSITIONUS5972909
OPPOSITIONWO2004073759
OPPOSITIONWO2006067608
OPPOSITIONWO2007077399
OPPOSITIONWO2008068297
OTHEREP1732620
OTHERFR2865737
OTHERUS5095037
OTHERUS5106615
OTHERWO2006067608

Non-Patent Literature (NPL) Citations (21) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- BELDA JOS� I ET AL, "Hyaluronic acid combined with mannitol to improve protection against free-radical endothelial damage: experimental model.", JOURNAL OF CATARACT AND REFRACTIVE SURGERY JUN 2005, (200506), vol. 31, no. 6, ISSN 0886-3350, pages 1213 - 1218, XP027831600
EXAMINATION- MAZZUCCO DAN ET AL, "Rheology of joint fluid in total knee arthroplasty patients.", JOURNAL OF ORTHOPAEDIC RESEARCH : OFFICIAL PUBLICATION OF THE ORTHOPAEDIC RESEARCH SOCIETY NOV 2002, (200211), vol. 20, no. 6, ISSN 0736-0266, pages 1157 - 1163, XP003028284
EXAMINATION- Megacrom, Cromapharma
EXAMINATION- Visiol, TRB Chemedica, Ophthalmic Line
OPPOSITION- Anonymous, "AUTOCLAVE, Wikipédia", (20191107), pages 1 - 6, URL: https://fr.wikipedia.org/w/index.php?title=Autoclave&oldid=164289367, XP055672443
OPPOSITION- Anonymous, "MegaCrom® Viscoelastic solution for intraocular use", Crona Pharma GmbH, (200208), page 1pp, XP003028282
OPPOSITION- Anonymous, "Synolis VA Hyaluronic Acid 40mg/ Sorbitol 80mg", Aptissen S/A, (201510), pages 1 - 64, XP055672456
OPPOSITION- Anonymous, "Visiol", TRB Chemedica AG, page 2pp, XP003028283
OPPOSITION- BELDA et al., "Hyaluronic acid combined with mannitol to improve protection against free-radical endothelial damage: Experimental Model", JOURNAL CATARACT AND REFRACTIVE SURGERY,, (200506), vol. 31, no. 6, pages 1213 - 1218, XP027831600
OPPOSITION- Endre A. BALAZS, "The physical properties of synovial fluid and the special rôle of hyaluronic acid", DISORDERS OF THE KNEE,, (1974), pages 63 - 75, XP002787888
OPPOSITION- H. Fam, J.T. Bryant, M. Kontopoulou, "RHEOLOGICAL PROPERTIES OF SYNOVIAL FLUIDS", Biorheology, (2007), vol. 44, pages 59 - 74, XP055672439
OPPOSITION- J.W. KUO, Practical Aspects of Hyaluronan based Medical products, Taylor & Francis Group, (20060000), page 92, XP055672452
OPPOSITION- J.W. KUO, Practical Aspects of Hyaluronan based Medical products, Taylor & Francis Group, (2006), pages 41 - 42, XP055672449
OPPOSITION- MAZZUCCO et al., "Rheology of joint fluid in total knee arthroplasty patients", JOURNAL OF ORTHOPAEDIC RESEARCH,, (2002), vol. 20, pages 1157 - 1163, XP003028284
OPPOSITION- Petr Ya Boykov, "3.5.2 Oxidation-Reduction Depolymerization of Hyaluronan", Hyaluronic Acid : Preparation, Properties, Application in Biology and Medicine, John Wiley & Sons, Ltd, (20150101), pages 88 - 89, doi:10.1002/9781118695920, ISBN 978-1-118-69593-7, XP093164333
OPPOSITION- STERN et al., "The many ways to cleave haluronan", BIOTECHNOLOGY ADVANCES,, (20070000), vol. 25, no. 6, pages 537 - 557, XP022277342
OPPOSITION- MENDOZA, "Inhibitory effects of different antioxidants on hyaluronan depolymerization", CARBOHYDRATE RESEARCH, (20070000), vol. 342, pages 96 - 102, XP005808572
OTHER- BELDA J.I. ET AL, "Hyaluronic acid combined with mannitol to improve protection against free-radical endothelial damage: Experimental Model", JOURNAL CATARACT REFRACTIVE SURGERY, (2005), vol. 31, pages 1213 - 1218, XP027831600
OTHER- CROMAPHARMA, MEGACROM, page 1, XP003028282
OTHER- MAZZUCCO D. ET AL, "Rheology of joint fluid in total knee arthroplasty patients", JOURNAL OF ORTHOPAEDIC RESEARCH, (2002), vol. 20, pages 1157 - 1163, XP003028284
OTHER- "Visiol", TRB CHEMEDICA OPHTHALMIC LINE, pages 1 - 2, XP003028283

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents